Skip to main content
Bioasis Technologies Inc. logo

Bioasis Technologies Inc. — Investor Relations & Filings

Ticker · BIOAF LEI · 529900ORRO8R51S5MW75 TSXV Manufacturing
Filings indexed 120 across all filing types
Latest filing 2022-12-20 Regulatory Filings
Country CA Canada
Listing TSXV BIOAF

About Bioasis Technologies Inc.

https://www.bioasis.us

Bioasis Technologies Inc. is a development-stage biopharmaceutical company focused on the research and development of proprietary technologies and products for Central Nervous System (CNS) diseases and brain-related disorders. Its core technology is the xB3 platform, a proprietary system designed to facilitate the transport and delivery of therapeutic agents across the challenging blood-brain barrier (BBB). The company's in-house programs aim to develop both symptomatic and disease-modifying treatments, as well as diagnostic technologies, addressing the limitations inherent in treating complex neurological conditions.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings
2022-12-20 English
Other.pdf
Regulatory Filings
2022-12-20 English
Other.pdf
Regulatory Filings
2022-12-20 English
Other.pdf
Regulatory Filings
2022-12-20 English
Other.pdf
Regulatory Filings
2022-12-20 English
Other.pdf
Regulatory Filings
2022-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.